Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISIS 449884 in type 2 diabetes mellitus
NCT02583919Phase 2Completed
- Sponsor
- Ionis Pharmaceuticals
- Start
- Sep 2015
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
A Phase 2 trial of ISIS 449884 in type 2 diabetes mellitus (T2DM), sponsored by Ionis Pharmaceuticals. Started Sep 2015; status: completed.
02
Drugs
ISIS 449884
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02583919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02583919.